Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study

Francesca Sofia Di Lisa, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Katia Cannita, Ugo De Giorgi, Fulvio Borella, Jennifer Foglietta, Anna Cariello, Antonella Ferro, Elisa Picardo, Marco Mitidieri, Valentina Sini, Simonetta Stani, Giuseppe Tonini, Daniele Santini, Nicla La Verde, Anna Rita Gambaro, Antonino Grassadonia, Nicola Tinari, Ornella Garrone, Giuseppina Sarobba, Lorenzo Livi, Icro Meattini, Giuliana D’Auria, Matteo Vergati, Teresa Gamucci, Mirco Pistelli, Rossana Berardi, Emanuela Risi, Francesco Giotta, Vito Lorusso, Lucia Rinaldi, Salvatore Artale, Marina Elena Cazzaniga, Fable Zustovich, Federico Cappuzzo, Lorenza Landi, Rosalba Torrisi, Simone Scagnoli, Andrea Botticelli, Andrea Michelotti, Beatrice Fratini, Rosa Saltarelli, Ida Paris, Margherita Muratore, Alessandra Cassano, Lorenzo Gianni, Valeria Gaspari, Enzo Maria Veltri, Federica Zoratto, Elena Fiorio, Maria Agnese Fabbri, Marco Mazzotta, Enzo Maria Ruggeri, Rebecca Pedersini, Maria Rosaria Valerio, Lorena Filomeno, Mauro Minelli, Paola Scavina, Mimma Raffaele, Antonio Astone, Roy De Vita, Marcello Pozzi, Ferdinando Riccardi, Filippo Greco, Luca Moscetti, Monica Giordano, Marcello Maugeri-Saccà, Alessandro Zennaro, Claudio Botti, Fabio Pelle, Sonia Cappelli, Flavia Cavicchi, Enrico Vizza, Giuseppe Sanguineti, Federica Tomao, Enrico Cortesi, Paolo Marchetti, Silverio Tomao, Iolanda Speranza, Isabella Sperduti, Gennaro Ciliberto, Patrizia Vici

Open source

DOI: 10.3389/fonc.2023.1152123
Published: 2023-05-16
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2023.1152123,
  title = {Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study},
  author = {Francesca Sofia Di Lisa and Eriseld Krasniqi and Laura Pizzuti and Maddalena Barba and Katia Cannita and Ugo De Giorgi and Fulvio Borella and Jennifer Foglietta and Anna Cariello and Antonella Ferro and Elisa Picardo and Marco Mitidieri and Valentina Sini and Simonetta Stani and Giuseppe Tonini and Daniele Santini and Nicla La Verde and Anna Rita Gambaro and Antonino Grassadonia and Nicola Tinari and Ornella Garrone and Giuseppina Sarobba and Lorenzo Livi and Icro Meattini and Giuliana D’Auria and Matteo Vergati and Teresa Gamucci and Mirco Pistelli and Rossana Berardi and Emanuela Risi and Francesco Giotta and Vito Lorusso and Lucia Rinaldi and Salvatore Artale and Marina Elena Cazzaniga and Fable Zustovich and Federico Cappuzzo and Lorenza Landi and Rosalba Torrisi and Simone Scagnoli and Andrea Botticelli and Andrea Michelotti and Beatrice Fratini and Rosa Saltarelli and Ida Paris and Margherita Muratore and Alessandra Cassano and Lorenzo Gianni and Valeria Gaspari and Enzo Maria Veltri and Federica Zoratto and Elena Fiorio and Maria Agnese Fabbri and Marco Mazzotta and Enzo Maria Ruggeri and Rebecca Pedersini and Maria Rosaria Valerio and Lorena Filomeno and Mauro Minelli and Paola Scavina and Mimma Raffaele and Antonio Astone and Roy De Vita and Marcello Pozzi and Ferdinando Riccardi and Filippo Greco and Luca Moscetti and Monica Giordano and Marcello Maugeri-Saccà and Alessandro Zennaro and Claudio Botti and Fabio Pelle and Sonia Cappelli and Flavia Cavicchi and Enrico Vizza and Giuseppe Sanguineti and Federica Tomao and Enrico Cortesi and Paolo Marchetti and Silverio Tomao and Iolanda Speranza and Isabella Sperduti and Gennaro Ciliberto and Patrizia Vici},
  year = {2023},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2023.1152123},
  url = {https://doi.org/10.3389/fonc.2023.1152123}
}

RIS

TY  - JOUR
TI  - Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study
AU  - Francesca Sofia Di Lisa
AU  - Eriseld Krasniqi
AU  - Laura Pizzuti
AU  - Maddalena Barba
AU  - Katia Cannita
AU  - Ugo De Giorgi
AU  - Fulvio Borella
AU  - Jennifer Foglietta
AU  - Anna Cariello
AU  - Antonella Ferro
AU  - Elisa Picardo
AU  - Marco Mitidieri
AU  - Valentina Sini
AU  - Simonetta Stani
AU  - Giuseppe Tonini
AU  - Daniele Santini
AU  - Nicla La Verde
AU  - Anna Rita Gambaro
AU  - Antonino Grassadonia
AU  - Nicola Tinari
AU  - Ornella Garrone
AU  - Giuseppina Sarobba
AU  - Lorenzo Livi
AU  - Icro Meattini
AU  - Giuliana D’Auria
AU  - Matteo Vergati
AU  - Teresa Gamucci
AU  - Mirco Pistelli
AU  - Rossana Berardi
AU  - Emanuela Risi
AU  - Francesco Giotta
AU  - Vito Lorusso
AU  - Lucia Rinaldi
AU  - Salvatore Artale
AU  - Marina Elena Cazzaniga
AU  - Fable Zustovich
AU  - Federico Cappuzzo
AU  - Lorenza Landi
AU  - Rosalba Torrisi
AU  - Simone Scagnoli
AU  - Andrea Botticelli
AU  - Andrea Michelotti
AU  - Beatrice Fratini
AU  - Rosa Saltarelli
AU  - Ida Paris
AU  - Margherita Muratore
AU  - Alessandra Cassano
AU  - Lorenzo Gianni
AU  - Valeria Gaspari
AU  - Enzo Maria Veltri
AU  - Federica Zoratto
AU  - Elena Fiorio
AU  - Maria Agnese Fabbri
AU  - Marco Mazzotta
AU  - Enzo Maria Ruggeri
AU  - Rebecca Pedersini
AU  - Maria Rosaria Valerio
AU  - Lorena Filomeno
AU  - Mauro Minelli
AU  - Paola Scavina
AU  - Mimma Raffaele
AU  - Antonio Astone
AU  - Roy De Vita
AU  - Marcello Pozzi
AU  - Ferdinando Riccardi
AU  - Filippo Greco
AU  - Luca Moscetti
AU  - Monica Giordano
AU  - Marcello Maugeri-Saccà
AU  - Alessandro Zennaro
AU  - Claudio Botti
AU  - Fabio Pelle
AU  - Sonia Cappelli
AU  - Flavia Cavicchi
AU  - Enrico Vizza
AU  - Giuseppe Sanguineti
AU  - Federica Tomao
AU  - Enrico Cortesi
AU  - Paolo Marchetti
AU  - Silverio Tomao
AU  - Iolanda Speranza
AU  - Isabella Sperduti
AU  - Gennaro Ciliberto
AU  - Patrizia Vici
PY  - 2023
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2023.1152123
UR  - https://doi.org/10.3389/fonc.2023.1152123
ER  -

APA

Lisa, F. S. D., Krasniqi, E., Pizzuti, L., Barba, M., Cannita, K., Giorgi, U. D., Borella, F., Foglietta, J., Cariello, A., Ferro, A., Picardo, E., Mitidieri, M., Sini, V., Stani, S., Tonini, G., Santini, D., Verde, N. L., Gambaro, A. R., Grassadonia, A., Tinari, N., Garrone, O., Sarobba, G., Livi, L., Meattini, I., D’Auria, G., Vergati, M., Gamucci, T., Pistelli, M., Berardi, R., Risi, E., Giotta, F., Lorusso, V., Rinaldi, L., Artale, S., Cazzaniga, M. E., Zustovich, F., Cappuzzo, F., Landi, L., Torrisi, R., Scagnoli, S., Botticelli, A., Michelotti, A., Fratini, B., Saltarelli, R., Paris, I., Muratore, M., Cassano, A., Gianni, L., Gaspari, V., Veltri, E. M., Zoratto, F., Fiorio, E., Fabbri, M. A., Mazzotta, M., Ruggeri, E. M., Pedersini, R., Valerio, M. R., Filomeno, L., Minelli, M., Scavina, P., Raffaele, M., Astone, A., Vita, R. D., Pozzi, M., Riccardi, F., Greco, F., Moscetti, L., Giordano, M., Maugeri-Saccà, M., Zennaro, A., Botti, C., Pelle, F., Cappelli, S., Cavicchi, F., Vizza, E., Sanguineti, G., Tomao, F., Cortesi, E., Marchetti, P., Tomao, S., Speranza, I., Sperduti, I., Ciliberto, G., & Vici, P. (2023). Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1152123

Source records

crossref · retrieved 2026-09-26T11:01:14.360Z